Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter - PubMed (original) (raw)

Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter

G Morahan et al. Proc Natl Acad Sci U S A. 1989 May.

Abstract

To study the effects of increased expression of major histocompatibility complex class I molecules on the development of self-tolerance, transgenic mice were produced that expressed the H-2Kb gene under the control of the metallothionein promoter. Administration of zinc enhanced transgene expression in liver, kidney and exocrine pancreas. No evidence suggestive of an autoimmune response was found in transgene-expressing tissues in mice otherwise allogeneic to H-2Kb. Despite this lack of responsiveness in vivo, T cells could be stimulated in vitro to lyse H-2Kb-bearing target cells. No infiltration was detected in transgenic mice after irradiation and reconstitution with bone marrow cells. When spleen cells were used for reconstitution, however, dense lymphocytic infiltration was seen, particularly in the portal tracts of the liver, and this was accompanied by piecemeal necrosis and apoptosis of periportal hepatocytes. This aggressive response progressively diminished with time, and by 12 weeks after reconstitution many of the portal tracts were free of infiltration while the others showed no accompanying necrosis. The picture at this stage was similar to that seen in chronic persistent hepatitis. These results suggest that, in addition to negative selection in the thymus, peripheral mechanisms not involving clonal deletion or permanent clonal anergy can prevent immune responses to self molecules.

PubMed Disclaimer

Similar articles

• Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver.
  Bertolino P, Heath WR, Hardy CL, Morahan G, Miller JF. Bertolino P, et al. Eur J Immunol. 1995 Jul;25(7):1932-42. doi: 10.1002/eji.1830250721. Eur J Immunol. 1995. PMID: 7621869
• A transgenic approach to the study of peripheral T-cell tolerance.
  Miller JF, Morahan G, Allison J, Hoffmann M. Miller JF, et al. Immunol Rev. 1991 Aug;122:103-16. doi: 10.1111/j.1600-065x.1991.tb00599.x. Immunol Rev. 1991. PMID: 1937538 Review.
• A study of graft versus host disease using bile duct implants under the kidney capsule.
  Hardy CL, Morahan G, Bhathal PS. Hardy CL, et al. Liver. 2000 Feb;20(1):16-26. doi: 10.1034/j.1600-0676.2000.020001016.x. Liver. 2000. PMID: 10726957
• A nondeletional mechanism of peripheral tolerance in T-cell receptor transgenic mice.
  Morahan G, Hoffmann MW, Miller JF. Morahan G, et al. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11421-5. doi: 10.1073/pnas.88.24.11421. Proc Natl Acad Sci U S A. 1991. PMID: 1662395 Free PMC article.
• Expression of class I histocompatibility antigens in defined tissues: effects on T cell function.
  Miller JF, Allison J, Morahan G, Cox KO, Mulebacher A, Blanden RV. Miller JF, et al. Semin Immunol. 1989 Nov;1(2):137-46. Semin Immunol. 1989. PMID: 15630815 Review.

Cited by

• The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.
  Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. Bowen DG, et al. J Clin Invest. 2004 Sep;114(5):701-12. doi: 10.1172/JCI21593. J Clin Invest. 2004. PMID: 15343389 Free PMC article.
• Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells.
  Lang J, Arnold B, Hammerling G, Harris AW, Korsmeyer S, Russell D, Strasser A, Nemazee D. Lang J, et al. J Exp Med. 1997 Nov 3;186(9):1513-22. doi: 10.1084/jem.186.9.1513. J Exp Med. 1997. PMID: 9348309 Free PMC article.
• Splenectomy induces biochemical remission and regeneration in experimental murine autoimmune hepatitis.
  Dywicki J, Buitrago-Molina LE, Noyan F, Schlue J, Iordanidis K, Manns MP, Wedemeyer H, Jaeckel E, Hardtke-Wolenski M. Dywicki J, et al. Eur J Med Res. 2022 Dec 10;27(1):284. doi: 10.1186/s40001-022-00933-3. Eur J Med Res. 2022. PMID: 36496477 Free PMC article.
• Do we need a pepton hypothesis?
  Lindahl KF. Lindahl KF. Immunogenetics. 1991;34(1):1-4. doi: 10.1007/BF00212305. Immunogenetics. 1991. PMID: 1713189 No abstract available.
• Autoimmune hepatitis: the realities and the uncertainties.
  Mackay IR. Mackay IR. Gastroenterol Jpn. 1991 Feb;26(1):102-8. doi: 10.1007/BF02779520. Gastroenterol Jpn. 1991. PMID: 1826101 Review. No abstract available.

References

1. 1. EMBO J. 1983;2(3):453-62 - PubMed
2. 1. Immunol Today. 1989 Feb;10(2):53-7 - PubMed
3. 1. J Immunol. 1977 Mar;118(3):1049-56 - PubMed
4. 1. Lancet. 1977 Oct 29;2(8044):914-9 - PubMed
5. 1. Adv Immunol. 1979;27:51-177 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)